ClinicalTrials.govpublic full text
A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis
rheumatoid arthritis, levilimab, ilsira, anti-il-6r, il-6 receptor inhibitors, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1046406
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.